These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 9144376
1. L-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytes. Ho WZ, Starr SE, Sison A, Douglas SD. Clin Diagn Lab Immunol; 1997 May; 4(3):352-7. PubMed ID: 9144376 [Abstract] [Full Text] [Related]
2. Cystamine inhibits human immunodeficiency virus-1 replication in cord blood-derived mononuclear phagocytes and lymphocytes. Ho WZ, Kaufman D, Song L, Cutillii JR, Douglas SD. Blood; 1996 Aug 01; 88(3):928-33. PubMed ID: 8704251 [Abstract] [Full Text] [Related]
3. N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice. Chen P, Bauer G, Mitchell J, Factor R, Markham R, Schwartz DH. AIDS; 1997 Jan 01; 11(1):33-41. PubMed ID: 9110073 [Abstract] [Full Text] [Related]
4. L-2-oxothiazolidine-4-carboxylic acid (procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor alpha chain. Lederman MM, Georges D, Dando S, Schmelzer R, Averill L, Goldberg D. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb 01; 8(2):107-15. PubMed ID: 7834394 [Abstract] [Full Text] [Related]
5. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Lai JP, Ho WZ, Zhan GX, Yi Y, Collman RG, Douglas SD. Proc Natl Acad Sci U S A; 2001 Mar 27; 98(7):3970-5. PubMed ID: 11274418 [Abstract] [Full Text] [Related]
6. Synthesis and in vitro anti-HIV activity in human monocyte-derived macrophages of 2-oxothiazolidine-4(R)-carboxylic acid derivatives. Oiry J, Puy JY, Mialocq P, Clayette P, Fretier P, Jaccard P, Dereuddre-Bosquet N, Dormont D, Imbach JL. J Med Chem; 1999 Nov 18; 42(23):4733-40. PubMed ID: 10579837 [Abstract] [Full Text] [Related]
7. A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus. Barditch-Crovo P, Noe D, Skowron G, Lederman M, Kalayjian RC, Borum P, Buier R, Rowe WB, Goldberg D, Lietman P. J Clin Pharmacol; 1998 Apr 18; 38(4):357-63. PubMed ID: 9590463 [Abstract] [Full Text] [Related]
8. Thiol suppression of human immunodeficiency virus type 1 replication in primary cord blood monocyte-derived macrophages in vitro. Lioy J, Ho WZ, Cutilli JR, Polin RA, Douglas SD. J Clin Invest; 1993 Feb 18; 91(2):495-8. PubMed ID: 7679409 [Abstract] [Full Text] [Related]
9. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication. Raju PA, Herzenberg LA, Herzenberg LA, Roederer M. AIDS Res Hum Retroviruses; 1994 Aug 18; 10(8):961-7. PubMed ID: 7811547 [Abstract] [Full Text] [Related]
10. Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages. Ho WZ, Zhu XH, Song L, Lee HR, Cutilli JR, Douglas SD. AIDS Res Hum Retroviruses; 1995 Apr 18; 11(4):451-9. PubMed ID: 7632461 [Abstract] [Full Text] [Related]
11. Effects of glutathione precursors on human immunodeficiency virus replication. Simon G, Moog C, Obert G. Chem Biol Interact; 1994 Jun 18; 91(2-3):217-24. PubMed ID: 8194136 [Abstract] [Full Text] [Related]
12. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Ojwang JO, Buckheit RW, Pommier Y, Mazumder A, De Vreese K, Esté JA, Reymen D, Pallansch LA, Lackman-Smith C, Wallace TL. Antimicrob Agents Chemother; 1995 Nov 18; 39(11):2426-35. PubMed ID: 8585721 [Abstract] [Full Text] [Related]
13. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines. Cassetta L, Fortunato O, Adduce L, Rizzi C, Hering J, Rovere-Querini P, Bianchi ME, Alfano M, Poli G. AIDS; 2009 Mar 13; 23(5):567-77. PubMed ID: 19194273 [Abstract] [Full Text] [Related]
14. L-2-oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human. Porta P, Aebi S, Summer K, Lauterburg BH. J Pharmacol Exp Ther; 1991 Apr 13; 257(1):331-4. PubMed ID: 2019996 [Abstract] [Full Text] [Related]
15. Infection of human macrophages with an endogenous tumour necrosis factor-alpha (TNF-alpha)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-alpha synthesis inhibitor RP 55778. Le Naour R, Clayette P, Henin Y, Mabondzo A, Raoul H, Bousseau A, Dormont D. J Gen Virol; 1994 Jun 13; 75 ( Pt 6)():1379-88. PubMed ID: 7515938 [Abstract] [Full Text] [Related]
16. [Study on anti-HIV-1 activities of composite extract from salvia yunnanensis]. Peng ZG, Qin DH, Teng L. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Aug 13; 28(8):711-5. PubMed ID: 18928096 [Abstract] [Full Text] [Related]
17. 3-(5-Dimethylamino-1-naphthalenesulphonyl)-2-(3-pyridyl)thiazolidine (YHI-1) selectively inhibits human immunodeficiency virus type 1. Premanathan M, Arakaki R, Ramanan S, Jinno S, Baba M, Yamashita S, Nakashima H. Antivir Chem Chemother; 1998 Sep 13; 9(5):423-30. PubMed ID: 9875395 [Abstract] [Full Text] [Related]
18. 9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy. Hung CL, Doniger J, Palini A, Snyder SW, Radonovich MF, Brady JN, Pantazis P, Sadaie MR. J Med Virol; 2001 Jul 13; 64(3):238-44. PubMed ID: 11424110 [Abstract] [Full Text] [Related]
19. Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression. Sundaravaradan V, Saxena SK, Ramakrishnan R, Yedavalli VR, Harris DT, Ahmad N. Proc Natl Acad Sci U S A; 2006 Aug 01; 103(31):11701-6. PubMed ID: 16868088 [Abstract] [Full Text] [Related]
20. Protection by L-2-oxothiazolidine-4-carboxylic acid of hydrogen peroxide-induced CD3zeta and CD16zeta chain down-regulation in human peripheral blood lymphocytes and lymphokine-activated killer cells. Corsi MM, Maes HH, Wasserman K, Fulgenzi A, Gaja G, Ferrero ME. Biochem Pharmacol; 1998 Sep 01; 56(5):657-62. PubMed ID: 9783734 [Abstract] [Full Text] [Related] Page: [Next] [New Search]